期刊文献+

Expression and Clinical Significance of HMGB1 and RAGE in Cervical Carcinoma 被引量:1

Expression and Clinical Significance of HMGB1 and RAGE in Cervical Carcinoma
下载PDF
导出
摘要 OBJECTIVE To study the expression level and clinical significance of HMGB1 and RAGE in cervical squamous epithelial carcinoma. METHODS Real time quantitative polymerase chain reaction(qRT-PCR) was employed to examine the expression of HMGB1(high mobility group box protein1),and RAGE(receptor for advanced glycation endproducts)in 60 cervical squamous epithelial carcinomas(CSEC),their paraneoplastic tissues(PS)and 30 normal cervix tissues(NCS). RESULTS The expression of HMGB1 in the CSEC samples and PS was similar(P>0.05),but higher compared to NCS(P<0.05).Overexpression of HMGB1 in the CESC tissues was significantly correlated with the tumor (P<0.05),and the presence of metastasis(P<0.01),but not correlated with the tumor diameter or tumor grade.RAGE expression was not significantly different among these tissue types,and showed no significant correlation with the the tumor stage,diameter or grade.But there was a significant positive correlation between RAGE expression and CSEC metastasis. CONCLUSION The results suggest that HMGB1 may be related to the proliferation,progression and metastasis of CSEC.The relationship of HMGB1/RAGE may be of importance for CSEC metastasis.HMGB1 presents a new potential gene target for prevention and treatment of CSEC. Study of HMGB1/RAGE expression will offer an experimental foundation for understanding the pathogenesis of CSES. OBJECTIVE To study the expression level and clinical significance of HMGB1 and RAGE in cervical squamous epithelial carcinoma. METHODS Real time quantitative polymerase chain reaction (qRT-PCR) was employed to examine the expression of HMGB1 (high mobility group box protein1), and RAGE (receptor for advanced glycation endproducts) in 60 cervical squamous epithelial carcinomas (CSEC), their paraneoplastic tissues (PS) and 30 normal cervix tissues (NCS). RESULTS The expression of HMGB1 in the CSEC samples and PS was similar (P〉0.05), but higher compared to NCS (P〈0.05). Overexpression of HMGB1 in the CESC tissues was significantly correlated with the tumor (P〈0.05), and the presence of metastasis (P〈0.01), but not correlated with the tumor diameter or tumor grade.RAGE expression was not significantly different among these tissue types, and showed no significant correlation with the the tumor stage, diameter or grade. But there was a significant positive correlation between RAGE expression and CSEC metastasis. CONCLUSION The results suggest that HMGB1 may be related to the proliferation, progression and metastasis of CSEC. The relationship of HMGBI/RAGE may be of importance for CSEC metastasis. HMGB1 presents a new potential gene target for prevention and treatment of CSEC. Study of HMGBI/RAGE expression will offer an experimental foundation for understanding the pathogenesis of CSES.
出处 《Chinese Journal of Clinical Oncology》 CSCD 2007年第5期343-346,共4页 中国肿瘤临床(英文版)
关键词 子宫颈 癌症 治疗方法 上皮细胞 HMGB1, RAGE, cervical squamous epithelial carcinoma, qRT-PCR.
  • 相关文献

参考文献12

  • 1王瑞良,苏青.RAGE及其配体的临床意义研究进展[J].国际内分泌代谢杂志,2006,26(3):160-162. 被引量:23
  • 2黄庆先,孙念峰,王国斌,王春友.高迁移率族蛋白1基因在胰腺癌组织中的表达及其临床意义[J].实用癌症杂志,2004,19(1):19-20. 被引量:16
  • 3Bonaldi T,,Langst G,Strohner R,et al.The DNA chao-erone HMGB1 facilitates ACF/CHRAC-dependent nu-cleosome sliding[].EMBO Journal.2003
  • 4K V?lp,M-L Brezniceanu,S B?sser,et al.Increasedexpression of high mobility group box1(HMGB1)isassociated with an elevated level of the antiapoptoticc-IAP2 protein in human colon carcinomas[].ColonCancer.2006
  • 5Xiang WX,Zhou JL,Zhou C.The High Mobility GroupProtein[].Chinese Journal of Cell Biology.2006
  • 6Gardella S,Andrei C,Ferrera D,et al.The nuclear pro-tein HMGB1 is secreted by monocytes via a non-clas-sical,vesicle-mediated[].EMBO Reports.2002
  • 7Evans A,Lennard TWJ,Davies BR,et al.Metastasis-associated or metastasis-inducing[].Journal of Surgical Oncology.2004
  • 8Ishiguro H.Receptor for advanced glycation end prod-ucts(RAGE)and its ligand,amphoterin are overex-pressed and associated with prostate cancer develop-ment[].Prostate.2005
  • 9Takada M,Hirata K,Ajiki T,et al.Expression of recep-tor for advanced glycation end products(RAGE)andMMP29 in human pancreatic cancer cells[].Hepatogas-troenterology.2004
  • 10Li JH,Huang XR,Zhu HJ,et al.Advanced glycationend products activate Smad signaling via TGF betadependent and independent mechanisms:implica-tions for diabetic renal and vascular disease[].The FASEB Journal.2004

二级参考文献27

  • 1Taguchi A, Blood DC, del Toro G, et al. Blockage of RAGE amphoterin signalling suppresses tumour growth and metastasis[J]. Nature,2000,405(6784) :354.
  • 2Thomas JO, Travers AA. HMG1 and 2,and related "architectural" DNA binding proteins [J]. Trends Biocbem Sci,2001,3(3):167.
  • 3Rauvala H, Huttunen H J, Fages C, Kaksonen M, et al. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell mobility [J]. Matrix Biol, 2000,19 (5) : 377.
  • 4Kuniyasu H, Chihara Y, Takahashi T,et al. Co-expression of receptor for advancedglycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer [J]. Oncol Rep, 2003,10 (2) : 445.
  • 5Takada M, Koizumi T,Toyama H,et al. Differential expression of RAGE in human pancreatic carcinoma cells [J]. Hepatogast roenterology, 2001,48 (42) - 1577.
  • 6Forbes JM, Thallas V, Thomas MC, et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J, 2003,17 : 1762-1764.
  • 7Candido R, Forbes JM, Thomas MC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes: Circ Res, 2003,92:785-792.
  • 8Haslbeck KM, Schleieher E, Bierhaus A, et al. The AGEVRAGE/NF-kappaB pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes,2005,113 : 288-291.
  • 9Prevost G, Fajardy I, Besmond C, et al. Polymorphisms of the neceptor of advanced glycation end products (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab, 2005, 31 : 35-39.
  • 10Kankova K, Stejskalova A, Hertlova M, et al. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant, 2005,20: 1093-1102.

共引文献37

同被引文献2

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部